Disruptive technologies, developing drugs, and building companies to treat disease
ALL WELCOME
Prof. Harvey Lodish will share some of his experiences as a researcher who has been active in biotechnology industry for over 35 years. He has started 7 companies including Genzyme and Millennium, and most recently Rubius, a company that is developing engineered red cells as a vehicle for introducing into the human body novel therapeutics that function for several months.
Date:
30 September 2015, 14:00 (Wednesday, -1st week, Michaelmas 2015)
Venue:
NDM Building, Headington OX3 7FZ
Venue Details:
Basement Seminar Room
Speaker:
Prof. Harvey Lodish (Whitehead Institute)
Organising department:
Ludwig Institute for Cancer Research, Oxford Branch
Organisers:
Mary Muers (Oxford Ludwig Institute, NDM Experimental Medicine),
Alexandra Ward (University of Oxford, Oxford Ludwig Institute, NDM Experimental Medicine)
Organiser contact email address:
alexandra.ward@ludwig.ox.ac.uk
Host:
Prof Xin Lu (Ludwig Cancer Research, Oxford Branch)
Part of:
Ludwig Institute Seminar Series
Topics:
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Mary Muers
